摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3S)-3-乙酰氨基丁酸苄酯 | 623932-51-4

中文名称
(3S)-3-乙酰氨基丁酸苄酯
中文别名
——
英文名称
(S)-3-Acetylamino-butyric acid benzyl ester
英文别名
Butanoic acid, 3-(acetylamino)-, phenylmethyl ester, (3S)-;benzyl (3S)-3-acetamidobutanoate
(3S)-3-乙酰氨基丁酸苄酯化学式
CAS
623932-51-4
化学式
C13H17NO3
mdl
——
分子量
235.283
InChiKey
RSPWSXRPXZNTSF-JTQLQIEISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    417.9±28.0 °C(Predicted)
  • 密度:
    1.096±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    17
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    55.4
  • 氢给体数:
    1
  • 氢受体数:
    3

SDS

SDS:7b703c06c2e0b0c0d306ce6cebee72fe
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    benzyl 3-aminocrotonate 在 bis(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate 吡啶氢气(-)-2,3-,双[(2R,5R)-2,5-二甲基磷]马来酸酐 作用下, 以 四氢呋喃甲醇 为溶剂, 25.0 ℃ 、101.33 kPa 条件下, 生成 (3S)-3-乙酰氨基丁酸苄酯
    参考文献:
    名称:
    新型手性双膦烷配体的合成,用于Rh(I)催化异构体β-酰基酰胺基丙烯酸酯的对映选择性氢化。
    摘要:
    已经描述了手性甲硅烷基膦酸酯的高度立体选择性的合成,其可以在无碱条件下有利地用作构建与DuPHOS有关的二膦的结构单元。在合成新的双膦环烷配体1(MalPHOS)中显示了甲硅烷基膦环烷的效用,该双膦环烷配体1的特征是马来酸酐骨架。配体与Rh(I)形成比类似Me-DuPHOS复合物具有更大咬合角P-Rh-P的复合物。两种配合物均已在具有药物相关性的不饱和α-和β-氨基酸前体的不对称氢化中进行了测试。在某些情况下,与Me-DuPHOS配合物相比,这种新型催化剂更具优势,特别是当使用(Z)构型的β-酰氨基丙烯酸酯作为底物时。
    DOI:
    10.1021/jo020453h
点击查看最新优质反应信息

文献信息

  • A Highly Tunable Family of Chiral Bisphospholanes for Rh-Catalyzed Enantioselective Hydrogenation Reactions
    作者:Jens Holz、Odalys Zayas、Haijun Jiao、Wolfgang Baumann、Anke Spannenberg、Axel Monsees、Thomas H. Riermeier、Juan Almena、Renat Kadyrov、Armin Börner
    DOI:10.1002/chem.200600033
    日期:2006.6.23
    enantioselectivities in methanol as the solvent. This may account for optimised steric and electronic effects. However, by changing the solvent catalysts with other backbones can give rise to excellent results. This gives proof that simple correlations between steric and electronic properties and results in the enantioselective hydrogenation frequently claimed in literature are not general.
    通过使用高度灵活和收敛的方法,已经制备了一组16种新的且密切相关的双膦环烷配体。每种合成可以在工业上相关的规模上进行。双膦在连接两个膦酸酯单元的桥的性质上不同。桥由三元,四元,五元和六元杂环或脂环族环形成。通过使用理论计算(DFT)和分析测量结果((31)P和(103)Rh NMR光谱,X射线结构分析)研究了双膦酮及其Rh预催化剂。研究表明,基于具有马来酸酐或马来酰亚胺桥的配体的催化剂在甲醇作为溶剂中具有不断优异的对映选择性。这可以说明优化的空间和电子效果。然而,通过改变溶剂催化剂与其他主链可以产生优异的结果。这证明了在空间性质和电子性质之间的简单关联以及导致文献中经常要求的对映选择性氢化的结果并不普遍。
  • Economic preparation of 1,3-diphenyl-1,3-bis(diphenylphosphino)propane: a versatile chiral diphosphine ligand for enantioselective hydrogenations
    作者:Natalia V. Dubrovina、Vitali I. Tararov、Axel Monsees、Renat Kadyrov、Christine Fischer、Armin Börner
    DOI:10.1016/s0957-4166(03)00595-0
    日期:2003.9
    The enantioselective hydrogenation of 1,3-diarylpropane-1,3-diones with chiral Ru(II)-diphosphine catalyst has been studied. In a first approach it was found, that Tol-BINAP together with Ru(COD)methallyl(2) formed the most selective catalyst. One of the C-2-symmetric enantiopure 1,3-diols obtained in turn was transformed via its 1,3-di-O-mesylate into 1,3-bisdiarylphosphines. One of them, 1,3-diphenyl-1,3-bis(diphenylphosphino)propane, could be advantageously utilized as a ligand for the efficient enantioselective Ru-catalyzed hydrogenation of its own 1,3-diketone precursor. Thus, the condition for a 'cross self-breeding' catalytic system is fulfilled. A further reduction of the preparation costs could be achived by application of RuCl3.H2O instead of other more expensive precatalyst precursors without compromosing the enantioselectivity. The ligand was used in the Rh(I)-catalyzed asymmetric hydrogenation of model substrates and beta-amino acid precursors where up to 97% ee could be achieved. (C) 2003 Elsevier Ltd. All rights reserved.
  • WO2006/45388
    申请人:——
    公开号:——
    公开(公告)日:——
  • New chiral 1,3-diphosphine ligands for Rh-catalyzed enantioselective hydrogenation: a search for electronic effects
    作者:Natalia V. Dubrovina、Vitali I. Tararov、Axel Monsees、Anke Spannenberg、Ioannis D. Kostas、Armin Börner
    DOI:10.1016/j.tetasy.2005.08.048
    日期:2005.11
    New electron-rich chiral 1,3-diphosphines of the BDPP type were prepared from 1, 3-diphenylpropane- 1,3-diol by an economically feasible synthetic approach. The a-donor properties of the phosphines were determined by measurement of J(P-31-Se-77) coupling constants in the corresponding phosphine selenides. For comparison related, but electronically different, 1,3-diphosphines were considered. The new diphosphines showed good enantioselectivities as ligands in the Rh-catalyzed enantioselective hydrogenation of benchmark substrates and beta-amino acid precursors (up to 98% ee). The electronic effects on the outcome of the enantioselective catalysis have been analyzed. (c) 2005 Published by Elsevier Ltd.
  • New chiral monodentate phospholane ligands by highly stereoselective hydrophosphination
    作者:Vitaliy Bilenko、Anke Spannenberg、Wolfgang Baumann、Igor Komarov、Armin Börner
    DOI:10.1016/j.tetasy.2006.06.047
    日期:2006.8
    New chiral phospholanes 6 were prepared in both enantiomeric forms starting from L- and D-tartaric acid. The key step in the synthetic sequence is the double hydrophosphination of unsaturated chiral bis(lactone) 9 by NaPhPH(BH3). This method was used for the first time in the formation of chiral phospholanes. The structure of phospholane 6a was confirmed by X-ray crystallography. sigma-Donor properties of the phospholanes were estimated by measurement of (1)J((PSe)-P-31-Se-77) coupling constants in the corresponding phosphine selenides. The new phospholanes were tested as ligands in the Rh-catalyzed enantioselective hydrogenation of functionalized standard olefins (65-92% ee). (c) 2006 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸